Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing photographed on Apr. 2, 2021, in Durham, N.C. Casey Toth ctoth@newsobserver.com The pharmaceutical giant Merck will stop producing the HPV,…
Read more Merck to end HPV vaccine production in Durham, laying off 154 workersNEW ORLEANS – While the ESSENCE Festival of Culture is known for fun times, great food, and link-ups with friends. However, it is a time for poignant conversation. Dr.…
Read more Merck’s Dr. Adrelia Allen emphasizes need for clinical trial diversity, especially for African AmericansOn this week’s episode of Fortune‘s Leadership Next podcast, co-host Alan Murray talks with former Merck CEO Ken Frazier. In a conversation recorded live at a Deloitte Next…
Read more Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politicsBy David Sachs Merck KGaA said that it has partnered with BenevolentAI and Exscientia on an initiative to discover more drugs with artificial intelligence, which the company says…
Read more Merck KGaA Enters Deal With BenevolentAI, Exscientia for AI-Based Drug DiscoveryYou wake up with a stuffy nose, so you head to the pharmacy, where a plethora of options awaits in the cold-and-flu aisle. Ah, how lucky you are…
Read more The Cold-Medication RacketDrugmaker Merck is suing the U.S. government over its plan to allow Medicare to negotiate prices for a handful of drugs, calling it “extortion.” The plan, part of…
Read more Merck sues U.S. government over plan to negotiate Medicare drug prices, claimingChina’s top drug regulator said Friday that it approved Merck & Co.’s Molnupiravir for emergency use on Thursday, as the country grapples with waves of infections after Beijing…
Read more China Approves Merck’s Molnupiravir for Emergency Use, Regulator SaysWSJ News Exclusive Business U.S. biotechnology company was the last of three suitors standing in an auction for Horizon Source link
Read more WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon TherapeuticsModerna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will…
Read more Moderna Stock Takes Off on Cancer Vaccine News
